Home > Journals > Medicine > European Journal of Dermatology > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma with a CD15 +CD30 phenotype


European Journal of Dermatology. Volume 17, Number 5, 441-2, September-October 2007, Clinical report

Free Article  

Author(s) : Naho Yoshizawa, Hiroaki Yagi, Takahiro Horibe, Masahiro Takigawa, Makoto Sugiura

Summary : Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma (CD8 +TCL) is an extremely rare entity with distinct clinicopathological features. While the CD15 antigen is typically associated with classic Hodgkin’s lymphoma, aggressive peripheral T-cell lymphomas, including advanced stage cutaneous T-cell lymphomas, rarely express this molecule. We report a case of primary cutaneous aggressive epidermotropic CD8 +TCL, in which lymphoma cells are CD15 +CD30 with a medium-to-large pleomorphic phenotype. Although the functional characteristics of CD15 expression in the cutaneous lymphomas are not fully understood, the poor prognosis of primary cutaneous aggressive epidermotropic CD8 +TCL might be associated with the presence of this molecule in our case.

Keywords : CD8 +TCL, CD8 + T-cell lymphoma, CTCL, Cutaneous T-cell lymphoma, EBV, Epstein-Barr virus, MF, Mycosis fungoides, TCR, T-cell receptor

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]